CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 58 filers reported holding CLEARSIDE BIOMEDICAL INC in Q3 2022. The put-call ratio across all filers is 2.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $144,000 | -19.6% | 98,097 | +25.3% | 0.02% | -8.3% |
| Q1 2022 | $179,000 | +9.1% | 78,274 | +30.8% | 0.02% | -11.1% |
| Q4 2020 | $164,000 | +100.0% | 59,832 | +12.5% | 0.03% | +92.9% |
| Q3 2020 | $82,000 | -19.6% | 53,197 | -1.7% | 0.01% | -75.4% |
| Q2 2020 | $102,000 | -17.1% | 54,092 | -57.4% | 0.06% | +307.1% |
| Q2 2019 | $123,000 | -61.6% | 127,018 | -45.2% | 0.01% | -56.2% |
| Q1 2019 | $320,000 | +150.0% | 231,876 | +93.2% | 0.03% | +113.3% |
| Q4 2018 | $128,000 | -79.2% | 120,010 | +20.0% | 0.02% | -55.9% |
| Q3 2018 | $615,000 | +15.2% | 100,010 | +100.4% | 0.03% | +30.8% |
| Q2 2018 | $534,000 | +506.8% | 49,910 | +296.1% | 0.03% | +420.0% |
| Q4 2017 | $88,000 | -84.3% | 12,600 | -80.4% | 0.01% | -86.8% |
| Q3 2017 | $561,000 | – | 64,200 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 2,467,500 | $14,805,000 | 7.67% |
| ACUTA CAPITAL PARTNERS, LLC | 1,316,268 | $7,898,000 | 2.79% |
| AJU IB Investment Co., Ltd. | 293,555 | $1,761,000 | 1.14% |
| RTW INVESTMENTS, LP | 4,206,765 | $25,241,000 | 0.38% |
| EAM Investors, LLC | 247,561 | $1,485,000 | 0.25% |
| Carmignac Gestion | 2,475,652 | $14,854,000 | 0.18% |
| Curi Wealth Management, LLC | 25,000 | $150,000 | 0.07% |
| CAXTON ASSOCIATES LP | 66,569 | $399,000 | 0.04% |
| Newman Dignan & Sheerar, Inc. | 21,523 | $129,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 316,600 | $1,900,000 | 0.04% |